Pinsky et al., 1996 - Google Patents
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.Pinsky et al., 1996
View PDF- Document ID
- 16455271536238377215
- Author
- Pinsky D
- Naka Y
- Liao H
- Oz M
- Wagner D
- Mayadas T
- Johnson R
- Hynes R
- Heath M
- Lawson C
- Stern D
- et al.
- Publication year
- Publication venue
- The Journal of clinical investigation
External Links
Snippet
The period of hypoxia is an important priming event for the vascular dysfunction that accompanies reperfusion, with endothelial cells (ECs) and neutrophils (PMNs) playing a central role. We hypothesized that EC Weibel-Palade (WP) body exocytosis during the …
- 206010021143 Hypoxia 0 title abstract description 83
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pinsky et al. | Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. | |
McMahon | Red blood cell deformability, vasoactive mediators, and adhesion | |
US6316403B1 (en) | Methods for treating an ischemic disorder and improving stroke outcome | |
Homeister et al. | Effects of complement activation in the isolated heart. Role of the terminal complement components. | |
Kyriakides et al. | Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex | |
US8128963B2 (en) | Methods for treating ischemic disorders using carbon monoxide | |
Miyagawa et al. | Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis | |
US7238469B2 (en) | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis | |
EP0951292B1 (en) | Treating an ischemic disorder and improving stroke outcome | |
Weyrich et al. | In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. | |
Chrzanowska-Wodnicka et al. | Rap1b is required for normal platelet function and hemostasis in mice | |
Maas et al. | Endothelial cell PECAM-1 confers protection against endotoxic shock | |
Etingin et al. | von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. | |
WO1998013058A9 (en) | Methods for treating an ischemic disorder and improving stroke outcome | |
AU2002318377A1 (en) | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis | |
Gebrane-Younes et al. | Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. | |
Hughes et al. | A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis | |
Senis et al. | Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo | |
Yeatman et al. | Human complement regulatory proteins protect swine lungs from xenogeneic injury | |
Murphy et al. | In vitro aspects of erythropoiesis | |
Lau et al. | The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation | |
WO2001068131A1 (en) | Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 | |
Seekamp et al. | The effect of anti-L-selectin (EL-246) on remote lung injury after infrarenal ischemia/reperfusion | |
Michelson | Flow cytometric analysis of platelets | |
Brenner et al. | The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model |